Clinical Trials Sponsored by Ad scientiam

Total 86 results

Ad scientiam

Recruiting

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD (OPTIS)

Neuromyelitis Optica

United States, France
Ad scientiam

Recruiting

MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect (MS-DETECT)

Multiple Sclerosis

Italy, France, Canada, United States, Denmark, Germany, Spain
Ad scientiam

Recruiting

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

Myasthenia Gravis

United States, France
Ad scientiam

Terminated

Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale (REDRESS)

Depressive Disorder, Major

France
Ad scientiam

Withdrawn

Impact of a Digital Solution (CardiCare™) on Cardiorespiratory Fitness Improvement in Patients Discharged From a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome

Acute Coronary Syndrome

France, Italy, Portugal, Spain
Ad scientiam

Completed

Digitalization of Neurofunctional Tests Via a Mobile Application DAMS for Multiple Sclerosis Patients (MSCopilot)

Multiple Sclerosis

France
Ad scientiam

Completed

Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy (ACTISLEEP)

Atopic Dermatitis Eczema

France
Ad scientiam

Not yet recruiting

A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis (MuControl-Sum)

Cystic Fibrosis

France
Ad scientiam

Recruiting

Descriptive Analysis of Real-world Data Collected With ME&MGopen

Myasthenia Gravis

United Kingdom, United States, Canada
Ad scientiam
Vertex Pharmaceuticals Incorporated

Not yet recruiting

Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis (MuControl)

Cystic Fibrosis

France
Ad scientiam
Roche Pharma AG

Completed

MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment. (DAM)

Multiple Sclerosis
Akeso
AD Pharma (Guangdong)

Completed

A Long-term Study of AK102 in Patients With Hypercholesterolemia

Hypercholesterolemia

China
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Homozygous Familial Hypercholesterolemia

China
Johns Hopkins University
AD RescueWear

Withdrawn

Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children

Atopic Dermatitis

United States
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Heterozygous Familial Hypercholesterolemia

China
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia

Hypercholesterolemia

China
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Hypercholesterolaemia

China
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | MGD-Meibomian Gland Dysfunction

United States
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
Galenika AD Beograd
Medicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)

Completed

Treatment of Resistant Hypertension: Cohort Study (TRYCORT)

Resistant Hypertension

Serbia
Rennes University Hospital
AD REM TECHNOLOGY; Ecole Normale Supérieure de Rennes

Completed

Effect of a Neuromuscular Electrical Stimulation Program on Walking Capacity in Peripheral Artery Disease Patients (ELECTROPAD)

Arteriopathy

France
Chang Gung Memorial Hospital
Scientis Pharma SA

Recruiting

Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation

Hyperpigmentation; Postinflammatory

Taiwan
UnionDerm
Skin of Color Society; Solta Medical; Scientis

Recruiting

Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma

Melasma

United States
Federico II University
ICAR (Istituto di Calcolo e Reti ad Alte Prestazioni) - CNR (Consiglio Nazionale...

Completed

Holographic Augmented Reality Versus Screen Visualisation of 3D Rendering Models for the Pre-operative Evaluation and Planning of Liver Resections

Hepatobiliary Neoplasm

Italy
University of Edinburgh
Chief Scientist Office of the Scottish Government

Completed

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS (GRACES)

Pregnancy | Gestational Diabetes

United Kingdom
University of Aberdeen
Chief Scientist Office of the Scottish Government

Completed

Recovery of Hand Function Through Mental Practice.

Stroke

United Kingdom
University of Dundee
Chief Scientist Office of the Scottish Government

Completed

Can Synbiotic Use Effect Gut Bacteria and the Immune Response in Older People

Aging

United Kingdom
University of Glasgow
Chief Scientist Office of the Scottish Government

Completed

Determinants of Corticosteroid Insensitivity in Smokers With Asthma

Smoking | Asthma | Steroid Resistance | Corticosteroid Insensitivity

United Kingdom
University of Edinburgh
Chief Scientist Office of the Scottish Government

Recruiting

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction (TARGET-Type 2)

Myocardial Infarction Type 2

United Kingdom
University of Dundee
Chief Scientist Office of the Scottish Government

Withdrawn

Resistant Starch and Non-starch Polysaccharide (Dietary Fibre) Intake and the Colonic Microbiome in Older People

Aging

United Kingdom
University of Dundee
Chief Scientist Office of the Scottish Government

Completed

Beta Blockers for the Treatment of Asthma

Asthma

United Kingdom
University of Dundee
Chief Scientist Office of the Scottish Government

Completed

Beta Blocker Therapy in Mild to Moderate Asthmatics (ANDA1)

Asthma

United Kingdom
Glasgow Caledonian University
Chief Scientist Office of the Scottish Government

Completed

Does Doing Pelvic Floor Exercise Ease Symptoms for Women Living With Prolapse?

Uterine Prolapse

United Kingdom
University of Edinburgh
Chief Scientist Office of the Scottish Government

Completed

Sodium Fluoride Imaging of Abdominal Aortic Aneurysms (SoFIA3)

Abdominal Aortic Aneurysm

United Kingdom
University of Aberdeen
Chief Scientist Office of the Scottish Government

Completed

Exploring New Technologies to Manage Cancer Pain in the Community

Neoplasms | Pain
Glasgow Royal Infirmary
Chief Scientist Office of the Scottish Government

Completed

Vitamin A and Very Low Birthweight Babies (VitAL)

Preterm Birth | Retinopathy of Prematurity

United Kingdom
NHS Lanarkshire
Chief Scientist Office of the Scottish Government; NHS Research Scotland

Completed

Autologous Blood Treatment for Ocular Surface Disease

Ocular Surface Disease

United Kingdom
University of Edinburgh
NHS Lothian; Chief Scientist Office of the Scottish Government

Completed

Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP) (SNAP)

Overdose

United Kingdom
University of Aberdeen
NHS Grampian; Chief Scientist Office of the Scottish Government

Completed

The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy (KANECT)

Depression

United Kingdom
University of Dundee
NHS Tayside; Chief Scientist Office of the Scottish Government

Completed

Medical Polypectomy and Predictors of Response

Nasal Polyps

United Kingdom
NHS Greater Glasgow and Clyde
Chief Scientist Office of the Scottish Government

Unknown

Glasgow Supported Self Management Trial (GSuST) (GSuST)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Edinburgh
NHS Lothian; Chief Scientist Office of the Scottish Government

Completed

Gap Junction Potentiation of Endothelial Function With Rotigaptide

Heart Disease | Vascular Disease

United Kingdom
University of Glasgow
NHS Fife; Chief Scientist Office of the Scottish Government

Unknown

Support for PARents of Children Living With ADHD - a Research Trial (SPARCLAR)

Attention Deficit Disorder With Hyperactivity

United Kingdom
University of Edinburgh
NHS Lothian; Chief Scientist Office of the Scottish Government

Completed

Promoting Physical Activity in People With Schizophrenia. (ProActiveS)

Schizophrenia
University of Edinburgh
NHS Lothian; Chief Scientist Office of the Scottish Government

Completed

Scottish COmputed Tomography of the HEART Trial (SCOT-HEART)

Angina Pectoris | Coronary Heart Disease

United Kingdom
University of Edinburgh
GE Healthcare; Chief Scientist Office of the Scottish Government

Completed

Development and Evaluation of Strategies to Improve Sedation Quality in InTensive Care (DESIST)

Critical Illness

United Kingdom
University of Aberdeen
NHS Grampian; Chief Scientist Office of the Scottish Government

Completed

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS)

Stage 2 or 3 Full Thickness Macular Hole

United Kingdom, Ireland
NHS Greater Glasgow and Clyde
Chief Scientist Office of the Scottish Government

Unknown

A Dose Finding Study for Pain Relief of a Broken Hip

Femoral Neck Fractures

United Kingdom
King's College London
Medical Research Council; Chief Scientist Office of the Scottish Government

Completed

Determinants of Adolescent, Now Young Adults, Social Well-being and Health: Longitudinal Follow-up (DASH)

Cardiovascular Risk Factor
Sheba Medical Center
D-Cure, Israel; Chief Scientist, The Israel Ministry of Science

Completed

Lifestyle Intervention in Obese Arab Women

Diabetes | Metabolic Syndrome

Israel

Clinical Trials Sponsored by Ad scientiam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations